Plain-English translation of NCT03222895 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The TIGER study is tracking lymph nodes in people who have had surgery to remove esophageal cancer. Researchers are collecting information from surgery specimens across 18 countries to map where cancer tends to spread and understand which lymph nodes matter most for predicting outcomes.
Many people with esophageal cancer don't know which lymph nodes are most important to treat, and current imaging tests before surgery sometimes miss where cancer has spread. This study will help doctors better understand these patterns so they can plan better treatments and know what to expect after surgery.
You likely qualify if…
You likely don't qualify if…
This is an observational study, meaning you won't do anything extra — you'll simply receive your standard cancer surgery and treatment as planned. Researchers will then analyze the tissue and lymph nodes removed during your surgery and follow your health for up to 5 years, tracking how you recover and whether the cancer returns. No additional procedures, appointments, or treatments are required for the study itself.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States
Brazil
Canada
China
Finland